Feops Heartguide News Today

NEW robust cardiovascular Advanced Visualization (AV) functionality through a dedicated Left Atrial Appendage (LAA) workflow, updated Transcatheter Mitral Valve Repair (TMVR) workflow, and various enhancements to streamline cardiac coronary imaging and pretreatment planning

NEW robust cardiovascular Advanced Visualization (AV) functionality through a dedicated Left Atrial Appendage (LAA) workflow, updated Transcatheter Mitral...

Today, FEops announced the publication of the PREDICT-LAA study in JACC: Cardiovascular Interventions, showing that Left Atrial Appendage Closure (LAAC) procedures planned by means of FEops HEARTguide

FEops announces Euan S. Thomson, PhD has been appointed as new Chairman. Euan Thomson succeeds veteran medical device executive Rob Michiels, who continues to support FEops as an independent board

Data from the PRECISE-TAVI study, presented at the PCR Valves 2022 convention in London shows that Transcatheter Aortic Valve Implantation (TAVI) procedures planned by means of FEops HEARTguideTM result

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

FEops, a cloud-based digital health player in the structural heart space, announces that it has secured a convertible loan of EUR 3.3m from its current investors and the EIC Fund in preparation of a

Five late-breaking presentations at TCT 2022 highlight the impact of Abbott's structural heart devices to repair or replace heart valves and close openings in the heart

Abbott’s today presented data supporting the use of its Amplatzer Amulet against Boston Scientific’s competing device.

FEops HEARTguide significantly improves efficiency and outcomes of LAAO procedures in the PREDICT-LAA Randomized Clinical Trial Data from the PREDICT-